Balyasny Asset Management
LYRA icon

Balyasny Asset Management’s Lyra Therapeutics LYRA Stock Holding History

Balyasny Asset Management’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-629
Closed -$196K – 2222
2024
Q1 		$196K Buy
629
+53
+9% +$16.5K ﹤0.01% 1794
2023
Q4 		$151K Buy
+576
New +$151K ﹤0.01% 1779